This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Validation of MMS Test for Cancer Monitoring (MMS-TM)

This study is currently recruiting participants.
See Contacts and Locations
Verified March 2016 by MedInnovation GmbH
Sponsor:
Collaborator:
HELIOS Klinikum Berlin-Buch
Information provided by (Responsible Party):
MedInnovation GmbH
ClinicalTrials.gov Identifier:
NCT02113683
First received: April 8, 2014
Last updated: March 10, 2017
Last verified: March 2016
  Purpose
The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Condition
Colo-rectal Cancer Stomach Cancer Melanoma Sarcoma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Validation of MMS Test to Detect Active Tumor Growth of Different Cancer Types Before and After Therapy, as Well as for Subsequent Relapse Control in Comparison to Conventional Methods

Resource links provided by NLM:


Further study details as provided by MedInnovation GmbH:

Primary Outcome Measures:
  • active tumor growth before and after cancer therapy [ Time Frame: up to 36 month ]

Estimated Enrollment: 100
Study Start Date: May 2014
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
MMS test
therapy monitoring of patients with colo-rectal or stomach disease or with melanoma

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients with primary diagnosis of cancer
Criteria

Inclusion Criteria:

  • Clinical diagnosis of colo-rectal cancer
  • Clinical diagnosis of stomach cancer
  • Suspected diagnosis of melanoma

Exclusion Criteria:

  • Colitis ulcerosa
  • Morbus Crohn
  • Cancer in time period two years before
  • Cancer therapy in time period two years before
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02113683

Contacts
Contact: Peter Reichardt, Dr. med. +49 30 9401 548 00 peter.reichardt@helios-kliniken.de

Locations
Germany
HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie Recruiting
Berlin, Germany, 13125
Contact: Peter Reichardt, Dr. med.    +49 30 9401 548 00    peter.reichardt@helios.kliniken.de   
Sponsors and Collaborators
MedInnovation GmbH
HELIOS Klinikum Berlin-Buch
Investigators
Principal Investigator: Katja Waterstradt, PhD MedInnovation GmbH
  More Information

Responsible Party: MedInnovation GmbH
ClinicalTrials.gov Identifier: NCT02113683     History of Changes
Other Study ID Numbers: MMS-tm14
Study First Received: April 8, 2014
Last Updated: March 10, 2017

Keywords provided by MedInnovation GmbH:
colo-rectal cancer
stomach cancer
melanoma
MMS test
therapy monitoring
Sarcoma

Additional relevant MeSH terms:
Melanoma
Sarcoma
Rectal Neoplasms
Stomach Neoplasms
Colorectal Neoplasms
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas
Neoplasms, Connective and Soft Tissue
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases
Stomach Diseases
Colonic Diseases

ClinicalTrials.gov processed this record on September 19, 2017